Biolife solutions reports first quarter 2024 financial results

Cell processing revenue increased 10% sequentially to $16.2 million gaap gross margin of 38%  and net loss of $10.2 million non-gaap adjusted gross margin expands from 40%  to 53%  and adjusted ebitda of $3.6 million  or 13% ex-gci freezers conference call begins at 4:30 p.m. eastern time today   bothell, wash.
BLFS Ratings Summary
BLFS Quant Ranking